These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"? Goette A; Röcken C Eur Heart J; 2004 Jul; 25(14):1185-6. PubMed ID: 15246635 [No Abstract] [Full Text] [Related]
5. Driver regions in atrial fibrillation associated with congestive heart failure: where are they, and what are they telling us? Nattel S J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1359-61. PubMed ID: 16403069 [No Abstract] [Full Text] [Related]
6. Isolated Atrial Amyloidosis in Patients with Various Types of Atrial Fibrillation. Sukhacheva TV; Eremeeva MV; Ibragimova AG; Vaskovskii VA; Serov RA; Revishvili ASh Bull Exp Biol Med; 2016 Apr; 160(6):844-9. PubMed ID: 27160887 [TBL] [Abstract][Full Text] [Related]
7. Local amyloidosis as a possible component of the atrial remodeling accompanying atrial fibrillation [corrected]. Leone O; Boriani G; Marinelli G; Rapezzi C J Am Coll Cardiol; 2008 Jun; 51(25):2444-5; author reply 2445. PubMed ID: 18565406 [No Abstract] [Full Text] [Related]
8. Atrial remodeling and atrial fibrillation: mechanisms and implications. Nattel S; Burstein B; Dobrev D Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):62-73. PubMed ID: 19808395 [No Abstract] [Full Text] [Related]
10. [Natriuretic peptides in atrial fibrillation. State of art and new concepts]. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2004 Feb; 60(2):154-7. PubMed ID: 15116163 [No Abstract] [Full Text] [Related]